TMCnet News
Rosetta Genomics Appoints Douglas Sites as EVP of Sales and Marketing [Professional Services Close - Up](Professional Services Close - Up Via Acquire Media NewsEdge) Rosetta Genomics reported the appointment of Douglas Sites to the newly-created position of Executive Vice President of Sales and Marketing. According to a company release, Sites will report to Kenneth Berlin, Rosetta's President and Chief Executive Officer. Most recently Sites was Vice President of Sales and Marketing at Asuragen. "We are delighted to welcome Doug to Rosetta's leadership team. His relevant skillset and depth of experience make him ideally suited to lead our commercial team as we expand Rosetta's commercial capabilities to drive sales of our Cancer of Origin test and prepare for the launch of our microRNA-based thyroid cancer assay, currently in development," said Berlin. "As we expand our oncology diagnostic offerings, Doug's insight into both the thyroid and oncology markets, along with his experience building teams, brands and revenues will be invaluable. We look forward to his stewardship of our commercial efforts and are confident he will be an important asset to our team." Prior to Asuragen, Sites was Director of Sales-Hematology and Oncology at Plus Diagnostics. ((Comments on this story may be sent to [email protected])) (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. [ Back To TMCnet.com's Homepage ] |